Neurovascular Compression in Atypical Odontalgia Patients by Kawasaki, Kaoru et al.
HEADACHE & FACIAL PAIN SECTION
Differences in the Clinical Characteristics of Persistent Idiopathic
Facial Pain (Atypical Odontalgia) Patients with or Without
Neurovascular Compression of the Trigeminal Nerve
Kaoru Kawasaki, DDS,*,† Shiori Sugawara, DDS,* Kazuya Watanabe, MSc,*
Chaoli Hong, DDS,* Trang Thi Huyen Tu , DDS* Takeshi Watanabe , DDS, PhD,*
Junichiro Sakamoto, DDS, PhD,‡ Norio Yoshino, DDS, PhD,‡ Takayuki Suga, DDS,*
Lou Mikuzuki, DDS, PhD,* Miho Takenoshita, DDS, PhD,* Satoshi Takada, DDS, PhD,†
Tohru Kurabayashi, DDS, PhD,‡ and Akira Toyofuku, DDS, PhD*
*Department of Psychosomatic Dentistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan;
†Department of Oral Surgery, School of Dentistry, Ohu University, Koriyama Fukushima, Japan; ‡Department of Oral and Maxillofacial Radiology,
Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
Correspondence to: Takeshi Watanabe, DDS, PhD, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan. Tel: þ81358035898; Fax: þ81358035898;
E-mail: watacdr@tmd.ac.jp.
Funding sources: This work was supported by KAKENHI from the Japan Society for the Promotion of Science (JSPS), Grant Number 19K10328. This
study was partially funded by the MEXT-Supported program for the Strategic Research Foundation at Private Universities (S1511018).
Conflicts of interest: The authors report no conflicts of interest related to this work.
Abstract
Background. Persistent idiopathic facial pain (PIFP) is the unexplained pain along the territory of the trigeminal nerve,
including nonorganic tooth pain called atypical odontalgia (AO). Though PIFP is debilitating to patients’ livelihood
and well-being, its pathophysiology remains poorly understood. Although neurovascular compression (NVC) of the
trigeminal nerve is known to be associated with trigeminal neuralgia (TN), the relationship between NVC and other
orofacial pains has not been fully elucidated. Methods. In this study, we investigated the differences in the character-
istics of PIFP (primarily AO) patients in the presence or absence of NVC. A retrospective analysis was performed on
data from 121 consecutive patients who had been diagnosed with unilateral PIFP according to the criteria of the
International Classification of Headache Disorders (ICHD)–3 and underwent magnetic resonance imaging scans of
the head. Results. In the group without NVC, characteristic findings were significant for psychiatric morbidity, somati-
zation, and pain disability, when compared with the group with NVC. Furthermore, the group without NVC exhibited
significant headache, noncardiac chest pain, shortness of breath, and pain catastrophizing. Conclusions. These results
suggest that PIFP patients can be divided into two groups: one consistent with a neuropathic pain phenotype when
NVC is present and a functional somatic symptom phenotype when presenting without NVC. Our findings may en-
able a more precise understanding of pathophysiology of PIFP and lead to better treatment strategies.
Key Words: Persistent Idiopathic Facial Pain (PIFP); Atypical Odontalgia (AO); Neurovascular Compression (NVC); Trigeminal Nerve;
Neuropathic Pain; Functional Somatic Symptom
Introduction
Persistent idiopathic facial pain (PIFP) is a chronic disor-
der along the territory of the trigeminal nerve. According
to the International Classification of Headache
Disorders, third edition (ICHD-3), and the International
Headache Society (IHS), PIFP is described as “persistent
facial and/or oral pain, with varying presentations but re-
curring daily for more than two hours per day over more
than three months, in the absence of clinical neurological
deficit” [1].
PIFP, formerly called atypical facial pain (AFP),
maybe the result of hyperactivity of central neurons
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secondary to damage of primary afferent neurons; on the
other hand, it has been suggested that PIFP is likely a
combination of both biological and psychosocial elements
[2]. Recently, it has been reported that some PIFP patients
show neuropathic pain characteristics [3]. However, the
pathophysiology of PIFP has not been fully investigated.
Facial pain may be widely divided into two types:
tooth-related and non-tooth-related [4]. Atypical odon-
talgia (AO) is considered a subtype of PIFP [5]. We have
previously reported that approximately half of AO
patients have psychiatric comorbidities, and this pain
might have a larger emotional component than a sensory
one in AO patients with psychiatric comorbidities [6].
We have also reported that patients AO and burning
mouth syndrome have higher pain intensity than AO-
only patients [7]. Regarding the characteristics of AO, it
has been reported that some patients have vascular-type
pain [8]. However, the neurovascular impact on AO/
PIFP pain has not been fully elucidated.
A correlation between trigeminal neuralgia (TN) and
neurovascular compression (NVC) has been shown for
some time. TN is typically a unilateral pain. NVC is pre-
sent 53% of the time on the symptomatic side of TN
patients, whereas it is present about 13% of the time on
the contralateral, asymptomatic side [9]. The relationship
between PIFP and NVC has been sparsely reported on,
with limited evidence reporting no association between
the two [10]. The correlation between NVC and non-TN
orofacial region pain, such as PIFP and AO, has not been
sufficiently studied.
In this study, we investigated the differences in the
characteristics of PIFP (primarily AO) patients in the
presence and absence of NVC.
Methods
Subjects
A retrospective analysis was performed on data from 121
consecutive patients diagnosed with unilateral PIFP
according to International Classification of Headache
Disorders (ICHD)–3 criteria. Patients subsequently
underwent a magnetic resonance imaging (MRI) scan of
the head. Definitive diagnosis was verified by the Chief
Professor of the clinic. All patients were initially seen at
the Psychosomatic Dental Clinic at Tokyo Medical and
Dental University Hospital, Tokyo, Japan, between April
2016 and February 2018. Inclusion criteria were as fol-
lows: 1) age >18 years, 2) unilateral tooth or facial pain
for more than six months, 3) absence of organic abnor-
mality per intraoral or radiographic examination.
Patients with an obvious peripheral or systemic cause of
pain were excluded from this study.
Ethics Approval and Consent to Participate
All patients consented to take part in this study and
signed a written informed consent. The study protocol
was approved by the Ethical Committee of the Faculty of
Dentistry at Tokyo Medical and Dental University
(TMDU; D2013–005).
Clinical Characteristics
Clinical characteristics were obtained from the patients’
medical charts, including demographic information (sex,
age, duration of illness). The investigators in this study
were all trained clinicians and researchers in our clinic.
Psychiatric History
Psychiatric history was investigated by reviewing referral
letters from attending psychiatrists of patients. All the
patients visiting our hospital had to submit referral letters
from their attending psychiatrist if they had a psychiatric
history. The psychiatric diagnoses in referral letters were
categorized according to the Diagnostic and Statistical
Manual of Mental Disorders, fifth edition (DSM-5).
Patients with mood disorders such as major depressive
disorder and dysthymic disorder were categorized as hav-
ing a “depressive disorders,” those with anxiety disorders
such as generalized anxiety disorder and obsessive-
compulsive disorder were categorized into “anxiety dis-
orders,” and those with bipolar disorders such as bipolar
I disorder and bipolar II disorder were categorized into
“bipolar disorders.”
As mentioned above, we adopted the psychiatric diag-
noses of attending psychiatrists, instead of basing diagno-
ses on clinical interview results. We excluded
information about psychiatric diagnoses from patients’
memory due to its inaccuracy.
MRI Protocol and Definitions
All patients underwent an MRI scan within one month af-
ter the first visit. All magnetic resonance (MR) data were
acquired using a 3D MRI scanner (Magnetom Spectra,
Siemens Healthcare, Erlangen, Germany) and a 16-chan-
nel head coil. The standard MRI protocol for trigeminal
neuralgia at our institution included the conventional
images for screening of the whole brain, MR angiography
(MRA), and MR cisternography. MRA was acquired us-
ing 3D time-of-flight (3D-TOF) MRA with the following
parameters: TR/TE 24/3.9 ms, flip angle 18, field of view
(FOV) 160 160 mm, matrix 320 192, section thick-
ness 0.5 mm, and number of slab 3, which was recon-
structed to a voxel size of 0.5 0.5 0.5 mm. Also, MR
cisternography was obtained using 3D constructive inter-
ference in steady state (3D-CISS) with the following
parameters: TR/TE 7.4/3.7 ms, flip angle 50, FOV
160 160 mm, matrix 320 320, section thickness
0.5 mm, which was reconstructed to a voxel size of
0.5 0.5 0.5 mm. These MR sequences were acquired
at the level of the root entry zone (REZ) of the trigeminal
nerve with a slab thickness of 44 mm.
All 3D-TOF and 3D-CISS were displayed in triplanar
views (transverse, coronal, and sagittal views) on the









niversity user on 14 Septem
ber 2021
visualization system and evaluated by two experienced
oral radiologists (JS, NY), who were blinded to symptom
side. NVC was defined as contact between a blood vessel
at the REZ and the trigeminal nerve without visible cere-
brospinal fluid between the two structures in the tripla-
nar views of 3D-CISS. REZ was defined as <5 mm from
the trigeminal root according to several previous studies
[11,12]. The type of the responsible blood vessel (artery
or vein) was evaluated using the triplanar views and
memory-in-pixel display of 3D-TOF MRA. If there was
disagreement or uncertainty about whether there was a
contact, it was considered no NVC in the data analysis.
Insets in Figure 1 provide examples of the degree and lo-
cation of trigeminal NVC.
Pain Scale
The characteristics of pain were evaluated using the
Short-Form McGill Pain Questionnaire (SF-MPQ) at the
initial visit. The contents of the SF-MPQ have been
described previously [13]. The SF-MPQ includes 15 items
(11 sensory and four affective). The 11 sensory items are
throbbing, shooting, stabbing, sharp, cramping, gnaw-
ing, hot-burning, aching, heavy, tender, and splitting.
The four affective items are tiring-exhausting, sickening,
fearful, and punishing-cruel. These items were rated as
follows: 0¼ none, 1¼mild, 2¼ discomforting,
3¼ distressing, 4¼ horrible, and 5¼ excruciating.
Pain Catastrophizing Scale
Pain catastrophizing was evaluated using the Pain
Catastrophizing Scale (PCS) at the first visit. The PCS
contains following 13 items: 1) I worry all the time about
whether the pain will end. 2) I feel I can’t go on. 3) It’s
terrible and I think it’s never going to get any better. 4)
It’s awful and I feel that it overwhelms me. 5) I feel I
can’t stand it anymore. 6) I become afraid that the pain
will get worse; 7) I keep thinking of other painful events.
8) I anxiously want the pain to go away. 9) I can’t seem
to keep it out of my mind. 10) I keep thinking about how
much it hurts. 11) I keep thinking about how badly I
want the pain to stop. 12) There’s nothing I can do to re-
duce the intensity of the pain. 13) I wonder whether
something serious may happen. These items were rated
as follows [14,15]: 0 ¼ not at all, 1 ¼ to a slight degree, 2
¼ to a moderate degree, 3 ¼ to a great degree, and 4 ¼
all the time.
Somatic Symptom Scale
The comorbidities of functional somatic symptoms were
examined using the Somatic Symptom Scale–8 (SSS-8) at
Figure 1. The examples of the degree and location of trigeminal neurovascular compression (NVC). A 73-year-old female with a
suspected right-sided trigeminal neuralgia. Transverse view of 3D-CISS (A), coronal view (B), sagittal view (C), and memory-in-pixel
display of 3D time-of-flight magnetic resonance angiography (D). NVC on the symptomatic nerve was revealed in the triplanar
views of 3D constructive interference in steady state (arrowheads). The responsible blood vessel was superior cerebellar artery
(arrow).
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the initial visit. The SSS-8 contains eight descriptors. The
eight descriptors have been previously reported
(Figure 2A) [16]. These descriptors were rated as follows:
0 ¼ not at all, 1 ¼ a little bit, 2 ¼ somewhat, 3 ¼ quite a
bit, 4 ¼ very much [16].
Self-Rating Depression Scale
Severity of depression was rated using Zung’s Self-Rating
Depression Scale (SDS), which consists of 20 questions.
The contents of the SDS have been previously described
[17]. Subjects with a total score of 38 are regarded as
normal, 39–52 as having a tendency to neuroticism, and
53 as having a tendency to depression [17].
Scale for Disability due to Chronic Pain
Disability due to chronic pain was examined using the
STarT Back five-item screening tool (STarT-G) at the
first visit. The five items are as follows: 1) It’s really not
safe for a person with a condition like mine to be physi-
cally active. 2) Worrying thoughts have been going
through my mind a lot of the time in the last two weeks.
3) I feel that my problem is terrible and that it’s never go-
ing to get any better. 4) In general in the last two weeks, I
have not enjoyed all the things I used to enjoy. 5)
Overall, how bothersome has your condition been in the
last two weeks? Items 1–4 were rated as follows: dis-
agree¼ 0, agree¼ 1. Item 5 was rated as follows: not at
all, slightly, moderately ¼ 0; very much, extremely¼ 1.
The STarT-G threshold was set to 4 [18].
Statistical Analysis
Data were analyzed using the Wilcoxon signed-rank test,
Student t test, and Fisher exact test using EZR (Easy R),
which is based on R and R Commander [19]. Results are
expressed as the mean (6 standard error [SE]) or the
number of patients (%).
Results
The Ratio of PIFP Patients Without NVC who Have
a Psychiatric History Is Larger than That with NVC
Table 1 shows the clinical–demographic data of patients
in the PIFP patients with NVC group (N¼ 49) and the
PIFP patients without NVC group (N¼ 72). There were
no significant differences in age, sex, duration of the chief
complaint, onset event, or distribution of pain location
between the two groups. However, psychiatric comor-
bidity (P¼ 0.44) was statistically higher in the PIFP
patients without NVC group compared with those in the
PIFP patients with NVC group. Moreover, we examined
scores from the STarT-G, which is the scale for disability
due to pain. The STarT-G cutoff score is 4. The number
of patients without NVC whose STarT-G score was >4
was significantly larger than that of patients with NVC
(Table 1.).
PIFP Patients Without NVC Tend to Have More
Severe Functional Somatic Symptoms Compared
with Those with NVC
We investigated the difference of psychosomatic tenden-
cies due to the presence or absence of NVC. We exam-
ined psychosomatic tendencies of patients using the SSS-
8. The SSS-8 value of PIFP patients without NVC was
significantly higher than that of PIFP patients with NVC
(Figure 2).
PIFP Patients Without NVC Tend to Have More
Severe Headache, Chest Pain, or Shortness of
Breath Compared with Those with NVC
SSS-8 can be classified by eight factors (Figure 3A). As a
result, PIFP patients without NVC have significantly
higher values in “headache” and “chest pain or shortness
of breath” compared with PIFP patients with NVC
(Figure 3B).
PIFP Patients Without NVC Tend to Have More
Severe Pain Catastrophizing than Those with NVC
Moreover, we examined pain catastrophizing using the
PCS and performed depression assessments using the
SDS. PCS scores were higher within the PIFP without
NVC group than the PIFP with NVC group, indicating
higher pain catastrophizing levels (Figure 4A). On the
other hand, there was no significant difference in the
value of SDS (Figure 4B).
PIFP Patients Without NVC Tend to Have Heavy
Pain Compared with Those Without NVC
The characteristics of pain were examined using the SF-
MPQ at the initial visit. As a result, the quantitative value
of “heavy” pain at the sensory component of SF-MPQ
descriptors was significantly higher in patients without
NVC than that in patients with NVC).
Figure 2. Neurovascular compression (NVC) (–) patients tend
to have severe functional somatic symptoms compared to
NVC(þ) patients. The severity of somatic symptoms was exam-
ined using the Somatic Symptom Scale–8 (SSS-8). Error bars
¼ SE (*P < 0.05, Student t test).
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Discussion
A large number of PIFP patients present with a history of
moderate trauma and subclinical sensory changes. Thus,
PIFP is considered a neuropathic pain syndrome [5]. On
the other hand, the relationship between PIFP and certain
psychiatric comorbidities has been well reported;
however, a causal relationship between the two remains
to be elucidated [20]. Moreover, it has been suggested
that there may be a relationship among functional so-
matic symptoms, anxiety, and depression, sometimes re-
ferred to as the “somatization–anxiety–depression triad”
[21,22]. Our data suggest that patients without NVC
tend to have psychiatric morbidity, disability due to pain
Table 1. Clinical characteristics of subjects
Characteristics NVC(þ) NVC(-) P Value
No. 49 72
Age, mean6SE, y 54.462.0 54.161.7 0.911
Sex, No. (%)
Male 11 (22) 15 (21)
Female 38 (78) 57 (79) 0.344
Duration of the problem, mean6SE, days 32.065.8 40.366.9 0.388
Triggered by dental procedures, No. (%) Absent 23 (47) 34 (44) 1.000
Present Root canal treatment 8 (16) 11 (14) 1.000
Extraction 4 (8) 6 (8) 1.000
Prosthesis treatment 5 (10) 6 (8) 0.756
Resin filling/inray 3 (6) 5 (7) 1.000
Orthodontic treatment 1 (2) 1 (1) 1.000
Oral surgery 5 (10) 8 (11) 1.000
Detail is unknown 0 6 (8) 0.060
Distribution of pain location, No. (%)
Maxillary right 7 (14) 17 (24) 0.250
Maxillary left 20 (41) 39 (54) 0.195
Mandibular right 7 (14) 18 (25) 0.119
Mandibular left 16 (33) 16 (22) 0.215
Facial pain 5 (10) 5 (7) 0.524
History of psychiatry, No. (%) 20 (41) 43 (60) 0.044
Schizophrenia 1 (2) 2 (3) 0.646
Depression 3 (6) 12 (17) 0.099
Depressive state 1 (2) 3 (4) 0.646
Bipolar disorder 3 (6) 1 (1) 0.302
Dysthymia 1 (2) 1 (1) 1.000
Anxiety disorder 6 (12) 9 (13) 1.000
Insomnia 2 (4) 2 (3) 1.000
Pain disorder 1 (2) 0 (0) 1.000
Detail is unknown 3 (6) 14 (20) 0.080
Because of oral symptom 0 (0) 1 (1) 1.000
STarT-G, positive (4), No. (%) 1 (2) 10 (14) 0.028
Statistical analyses of age and duration of the problem were performed using the Student t test. The others were performed using the Fisher exact test.
NVC ¼ neurovascular compression; STarT-G ¼ STarT Back five-item screening tool.
Figure 3. Neurovascular compression (NVC) (–) patients tend to have severe headache chest pain or shortness of breath compared
with NVC(þ) patients. The severity of each somatic symptoms was examined using the Somatic Symptom Scale–8 (SSS-8). A) The
SSS-8 contains eight descriptors. B) Error bars ¼ SE (*P < 0.05, Student t test).
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(Table 1), and psychosomatic complaints compared with
the group with NVC (Figures 2 and 3). Until now, sub-
types of PIFP patients have not been described in terms of
presence or absence of accompanying NVC. Our findings
may enable a more detailed understanding of the rela-
tionship between PIFP, psychiatric comorbidity, func-
tional somatic symptoms, and NVC.
NVC has been reported to be associated with TN [23–
25]. In recent years, it has been reported that severe NVC
is present more in the symptomatic side than in the
asymptomatic side of TN patients [9]. On the other
hand, in a similar study of PIFP patients, it has been
reported that there was no difference between the symp-
tomatic side and asymptomatic side [10]. These reports
examined the severity of NVC. With respect to mild
NVC, it has been suggested that there is no impact on
these symptoms. Although in this study we did not exam-
ine severity of NVC, differences in the characteristics of
PIFP patients with or without NVC were demonstrated.
Our findings suggest that mild NVC, excluding the con-
dition TN, can be a predisposition to one of the subtypes
of PIFP.
A lack of association between PIFP and NVC has been
reported [10,26,27]. These reports have suggested that
there is no association between the presence or absence
of PIFP symptoms and the presence or absence of NVC.
However, our results suggest that there are some charac-
teristic differences between PIFP patients with and with-
out NVC. Therefore, our results are not inconsistent with
these reports.
Our previous studies have shown that pain might have
a larger emotional component than a sensory one in AO
(a subtype of PIFP) patients with comorbid psychiatric
disorders [6]. In this study, we showed that PIFP patients
without NVC were more prone to have psychiatric co-
morbidity than patients with NVC. Moreover, the group
without NVC tended to have “heavy” pain compared
with the group with NVC. Although patients without
NVC tend to have psychiatric comorbidities, there was
no difference in the emotional component of the SF-
MPQ between the two groups (Table 2). The difference
in the characteristics of PIFP patients with or without
NVC is not only in psychiatric history but also in other
several factors. Our results suggest that these other
Figure 4. The value of Pain Catastrophizing Scale (PCS) of the group without neurovascular compression (NVC) showed signifi-
cantly higher than that with NVC. A) Pain catastrophizing was examined using the PCS. B) The severity of depression was rated us-
ing Zung’s Self-Rating Depression Scale (SDS). Error bars ¼ SE (*P < 0.05, Student t test).
Table 2. Comparison of SF-MPQ between NVC(þ) and NVC(–) patients
NVC(þ) NVC(–) P Value
SF-MPQ descriptors Sensory Throbbing, mean6SE 0.9160.16 0.9760.13 0.78
Shooting, mean6SE 0.4160.11 0.5360.10 0.431
Stabbing, mean6SE 0.8760.16 0.760.12 0.386
Sharp, mean6SE 0.8560.16 0.860.13 0.828
Cramping, mean6SE 160.27 1.0260.13 0.956
Gnawing, mean6SE 0.660.14 0.860.13 0.305
Hot-burning, mean6SE 0.2660.12 0.456 0.11 0.231
Aching, mean6SE 1.1260.18 1.7360.19 0.055
Heavy, mean6SE 0.7860.16 1.2460.13 0.029
Tender, mean6SE 1.260.15 1.2460.14 0.823
Splitting, mean6SE 0.3760.13 0.2460.09 0.39
Affective Tiring-exhausting, mean6SE 1.4160.18 1.5660.13 0.502
Sickening, mean6SE 0.7460.15 1.0960.13 0.083
Fearful, mean6SE 0.4660.14 0.7360.12 0.147
Punishing-cruel, mean6SE 0.7260.15 0.8660.12 0.438
Statistical analysis was performed using the Student t test.
NVC ¼ neurovascular compression; SF-MPQ ¼ Short-Form McGill Pain Questionnaire.
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several factors may affect the quality of the pain of PIFP
patients without NVC.
Tricyclic antidepressants (TCAs) such as amitriptyline
are known to be effective for chronic pain in the orofacial
region [28–31]. However, the therapeutic response to a
TCA is known to be limited [32]. One possible cause of
the limited efficacy of antidepressants is the heterogeneity
of the PIFP patient population [33]. The current study
highlights the differences in the characteristics of PIFP
patients in the presence or absence of NVC. However,
we have yet to examine differences in treatment response
between patients with and without NVC. Although there
is no correlation between the response of TCA and NVC,
neuropathic medication is likely to be effective in patients
with NVC. There is a need to examine the pharmacologic
response of PIFP patients with or without NVC. It may
be possible to select a more appropriate medication for
PIFP patients by understanding the underlying patho-
physiology in cases with or without NVC.
Conclusions
It has been suggested that there are some differences in
the characteristics of PIFP patients with or without NVC,
such as psychiatric morbidity and severity of somatic
symptoms. Our findings may further our understanding
of the pathophysiology of PIFP and eventually lead to im-
proved treatment options.
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